• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Crowdfunding for Medical Devices Could Be A Passing Fad

by HITC Staff 09/30/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Crowdfunding for Medical Devices

While it is well established in other areas of business, crowdfunding for medical devices presents a new set of challenges and opportunities, and could become a passing fad rather than an encouraging new trend in the healthcare sector, says an analyst with research and consulting firm GlobalData.

According to Shashank Settipalli, GlobalData’s Analyst covering Medical Devices, although medical device regulatory agencies, such as the US Food and Drug Administration (FDA), have not enacted concrete directives on crowdfunded medical devices, questions arise about whether or not a contributor is participating in a sale of an unapproved product.

Threats to Crowdfunded Medical Devices

Perhaps anticipating a regulatory crackdown by the FDA, Cur, a California-based device manufacturer, has updated the terms of service on its website to emphasize that contributors are financing a work-in-progress and are not, in fact, making a direct purchase.

Settipalli explains: “The success of crowdfunded medical technology depends on whether many of these devices eventually achieve regulatory approval. Even though the hurdles of initial financing are overcome, medical devices need to follow the requisite pathways for market entry.

“One of the main threats to crowdfunded medical devices is the difficulty in obtaining consistent success and, as a result, firms seeking crowdfunding need to make their contributors aware of the inherent risks and expectations in the uncertain development process.”

Crowdfunding for Medical Devices Success = Smaller, Simpler Devices

As a consequence, the analyst believes that crowdfunding may be most beneficial for smaller, simpler devices that can quickly earn approval and treat a wider pool of patients with quality of life problems, such as sleep apnea and chronic pain.

Settipalli continues: “Crowdfunding may provide burgeoning start-ups with the vital capital to design, develop, and test devices that treat both rare and commonplace medical conditions. 

“Furthermore, by directly involving consumers and end users, entrepreneurs can gauge the market size and unmet needs of a particular therapy area,” the analyst concludes.

Featured image credit: Rocío Lara via cc

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: crowdfunding in healthcare, Healthcare Crowdfunding

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |